Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backernews2025-12-10T19:21:12+00:00December 10th, 2025|Endpoints News|
USAntibiotics scores sped-up approval for amoxicillinnews2025-12-10T19:11:01+00:00December 10th, 2025|Endpoints News|
Adare Pharma shutters Philadelphia site and lays off over 100 staffersnews2025-12-10T16:39:05+00:00December 10th, 2025|Endpoints News|
In a first, FDA approves a gene therapy from a nonprofitnews2025-12-10T16:02:33+00:00December 10th, 2025|Endpoints News|
J&J joins ‘menin party’ at ASH; GSK to work with Oxford BioTherapeuticsnews2025-12-10T15:34:26+00:00December 10th, 2025|Endpoints News|
#SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%news2025-12-10T13:15:32+00:00December 10th, 2025|Endpoints News|
PsiThera gets $47.5M for oral I&I drugs after spinning out from Roivantnews2025-12-10T12:00:41+00:00December 10th, 2025|Endpoints News|
Formation Bio signs deal for TYK2 drug from China’s Lynknews2025-12-10T12:00:15+00:00December 10th, 2025|Endpoints News|
UK lowers new medicine rebate scheme to 14.5% for 2026news2025-12-10T11:49:17+00:00December 10th, 2025|Endpoints News|
D3 Bio raises $108M to take next-gen KRAS G12C drug into Phase 3news2025-12-10T11:40:43+00:00December 10th, 2025|Endpoints News|
